Results 161 to 170 of about 79,537 (233)

Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer. [PDF]

open access: yesCancer Discov
Siegel F   +25 more
europepmc   +1 more source

ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer. [PDF]

open access: yesWorld J Surg Oncol
Gao Q   +5 more
europepmc   +1 more source

Corrigendum to Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models. [PDF]

open access: yesJ Clin Invest
Devarajan R   +18 more
europepmc   +1 more source

The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study. [PDF]

open access: yesMedicina (Kaunas)
Yıldız C   +10 more
europepmc   +1 more source

Massive breast fat necrosis with invasive breast cancer: A case report. [PDF]

open access: yesOncol Lett
Zhang A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy